SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Apr-22 7:07 PM View: | Sierra Oncology, Inc. (SRRA) | 27-Apr-22 | Acquisition (other) | 16,030 | -- | -- | < 1% 2.14M to 2.16M | |
29-Apr-22 7:07 PM View: | Sierra Oncology, Inc. (SRRA) | 27-Apr-22 | Disposition (other) | 2,139,770 | -- | -- | (99%) 2.16M to 16.03K | |
21-Apr-22 6:04 PM View: | Inozyme Pharma, Inc. (INZY) | 19-Apr-22 | Private Purchase | 1,355,000 | $3.69 | $4,999,950.00 | 48% 2.82M to 4.17M | |
02-Feb-22 9:25 PM View: | Sierra Oncology, Inc. (SRRA) | 02-Feb-22 | Purchase Duplicate | 175,000 | $27.00 | $4,725,000.00 | 9% 1.96M to 2.14M | |
27-Jan-22 9:23 PM View: | Sierra Oncology, Inc. (SRRA) | 25-Jan-22 | Exercise (in-the money or at-the-money) Duplicate | 487,451 | $13.20 | $6,434,350.00 | 33% 1.48M to 1.96M | |
11-May-21 8:29 PM View: | Tourmaline Bio, Inc. (TRML) | 11-May-21 | Conversion Duplicate | 2,985,780 | -- | -- | 100% 0 to 2.99M | |
11-May-21 8:29 PM View: | Tourmaline Bio, Inc. (TRML) | 11-May-21 | Purchase Duplicate | 235,000 | $17.00 | $3,995,000.00 | 8% 2.99M to 3.22M | |
18-Nov-20 7:11 PM View: | 89bio, Inc. (ETNB) | 16-Nov-20 | Acquisition (other) | 5,944 | -- | -- | < 1% 2.6M to 2.61M | |
18-Nov-20 7:11 PM View: | 89bio, Inc. (ETNB) | 16-Nov-20 | Disposition (other) Duplicate | 850,000 | -- | -- | (33%) 2.61M to 1.76M | |
01-Sep-20 7:33 PM View: | Threshold Pharmaceuticals I... (MTEM) | 28-Aug-20 | Market Sale | 3,496 | $10.75 | $37,568.40 | (< 1%) 3.21M to 3.2M | 7% |
28-Jul-20 6:20 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Conversion Duplicate | 2,194,380 | -- | -- | 100% 0 to 2.19M | |
28-Jul-20 6:20 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Purchase | 625,000 | $16.00 | $10,000,000.00 | 28% 2.19M to 2.82M | |
14-Jul-20 8:11 PM View: | 89bio, Inc. (ETNB) | 10-Jul-20 | Purchase Duplicate | 109,090 | $27.50 | $2,999,980.00 | 4% 2.49M to 2.6M | |
28-May-20 9:07 PM View: | Threshold Pharmaceuticals I... (MTEM) | 26-May-20 | Acquisition (other) | 6,991 | -- | -- | < 1% 4.2M to 4.21M | |
28-May-20 9:07 PM View: | Threshold Pharmaceuticals I... (MTEM) | 26-May-20 | Disposition (other) | 1,000,000 | -- | -- | (24%) 4.21M to 3.21M | |
31-Jan-20 5:45 PM View: | Sierra Oncology, Inc. (SRRA) | 29-Jan-20 | Conversion Duplicate | 1,477,320 | -- | -- | 100% 0 to 1.48M | |
27-Nov-19 4:47 PM View: | Threshold Pharmaceuticals I... (MTEM) | 25-Nov-19 | Private Purchase Duplicate | 937,000 | $8.00 | $7,496,000.00 | 29% 3.26M to 4.2M | (9%) |
13-Nov-19 7:02 PM View: | 89bio, Inc. (ETNB) | 13-Nov-19 | Conversion | 1,916,790 | -- | -- | 333% 575.0K to 2.49M | |
13-Nov-19 7:02 PM View: | 89bio, Inc. (ETNB) | 11-Nov-19 | Purchase | 575,000 | $16.00 | $9,200,000.00 | 100% 0 to 575.0K | |
02-Nov-18 7:26 PM View: | Axonics, Inc. (AXNX) | 02-Nov-18 | Conversion | 2,400,000 | -- | -- | 100% 0 to 2.4M | |
02-Nov-18 7:26 PM View: | Axonics, Inc. (AXNX) | 02-Nov-18 | Purchase | 533,333 | $15.00 | $8,000,000.00 | 22% 2.4M to 2.93M | |
25-Sep-18 4:43 PM View: | Threshold Pharmaceuticals I... (MTEM) | 21-Sep-18 | Market Purchase Duplicate | 365,000 | $5.50 | $2,007,500.00 | 13% 2.9M to 3.26M | 82% |